author-photo

Maite Gorostegui

Hospital Sant Joan de Déu Barcelona

9

Papers

14

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
The role of autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy: Results of 2 consecutive studies in a single referral institution.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic.

2020 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (9)
Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of HITS pilot/phase II study.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)